Kidney biopsy confirmed 24% of clinical diagnoses of acute interstitial nephritis and 57% of acute tubular injury diagnoses, ...

Chemoresection may be a minimally invasive option for recurrent Ta, intermediate-risk non-muscle-invasive bladder cancer (NMIBC).

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder ...

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).

Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery ...

A refined liquid biopsy that accounts for age-related background mutations has enabled clinicians to identify patients with ...

A new study from Stanford researchers reveals a non-invasive urine test that can accurately detect residual bladder cancer ...

A groundbreaking noninvasive urine test is transforming how doctors predict bladder cancer treatment outcomes. This ...

Bladder cancer is probably a bit further down your list of concerns than other cancers and conditions. Still, knowing the ...

Bladder cancer is a heterogeneous malignancy with diverse clinical outcomes, and conventional pathological assessment alone is insufficient to capture its underlying biology. Gene expression profiling ...